Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
American Heart Journal|December 19, 2006
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertensionJoern Tongers, Ben Schwerdtfeger, Gunnar Klein, et al.European Journal of Heart Failure|June 23, 2022
Giant cell myocarditis after first dose of BNT162b2 - a case reportValentin G Hirsch, Sven Schallhorn, Carolin Zwadlo, et al.European Heart Journal|October 28, 2008
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarctionMortimer Korf-Klingebiel, Tibor Kempf, Thomas Sauer, et al.European Heart Journal|December 27, 2011
Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndromeChristian Widera, Michael J Pencina, Allison Meisner, et al.Journal of Molecular and Cellular Cardiology|August 3, 2011
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndromeChristian Widera, Shashi K Gupta, Johan M Lorenzen, et al.Clinical Chemistry|December 23, 2006
Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assayTibor Kempf, Rüdiger Horn-Wichmann, Georg Brabant, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 20, 2020
Advanced Preconditioning: Impella 5.5 Support for Decompensated Heart Failure Before Left Ventricular Assist Device SurgeryTobias König, Jasmin S Hanke, Guenes Dogan, et al.Frontiers in Cardiovascular Medicine|September 23, 2022
Cinefluoroscopy for assessment of mechanical heart valves with suspected dysfunctionAnselm A Derda, Marvin M Marquardt, Andreas Martens, et al.Circulation|March 19, 2003
Downregulation of cytoskeletal muscle LIM protein by nitric oxide: impact on cardiac myocyte hypertrophyJörg Heineke, Tibor Kempf, Theresia Kraft, et al.Circulation|September 13, 2007
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Bo Lagerqvist, et al.Pageof 10